Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 86 results found. Search for [ COVID-19 antibody treatment ]

Results 1 to 21 of 86
Reuters
November 22, 2020
The agency said the antibodies are not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19


BusinessToday.In
November 19, 2020
Convalescent Plasma Therapy (CPT) or passive immunotherapy has been tried in the past for treatment of viral infections like H1N1, Ebola and SARS-CoV-1 etc


PB Jayakumar
November 18, 2020
Cipla will sell these kits across 25 markets in Asia, Middle-East and North Africa, Latin America, EU and Australia


Associated Press
November 13, 2020
Trump, fresh off his reelection loss to President-elect Joe Biden, remains angry that an announcement about progress in developing a vaccine for the disease came after Election Day


Reuters
November 11, 2020
The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data


Chitranjan Kumar
November 6, 2020
Cipla Q2 results: India business grew by 17 per cent YoY and 33 per cent QoQ on the back of strong growth across businesses and continued servicing of patients with COVID-19 portfolio


PB Jayakumar
November 3, 2020
Zydus today said it has filed an Investigational New Drug (IND) application for 'ZYIL1', an oral drug candidate, that has found to be effective in pre-clinic studies to control inflammation in COVID-19 related diseases


PTI
October 31, 2020
Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients


Chitranjan Kumar
October 28, 2020
Validated and approved by ICMR and the National Institute of Virology (NIV), Pune, Cipla's ELIfast is found to have specificity and sensitivity of 99.33 per cent and 92 per cent, respectively


PTI
October 27, 2020
Speaking to reporters after a meeting with AstraZeneca Managing Director Gagan Singh Bedi, he said the first phase of trials of the vaccine were encouraging


Reuters
October 27, 2020
President Donald Trump received a similar experimental antibody drug from Regeneron Pharmaceuticals Inc on an emergency basis when he was sickened with the coronavirus earlier this month


PB Jayakumar
October 22, 2020
Serum Institute of India (SII) has teamed up with Merck KGaA, Germany, to develop COVID-19 fighting monoclonal antibodies (mAbs), made by cloning a unique white blood cell to increase immunity and fight diseases, along with drug research driven nonprofit scientific research organization IAVI and Scripps Research


PTI
October 20, 2020
Israel had claimed in August that it already has the vaccine against the coronavirus \"in hand\" but it has to go through regulatory processes that would begin with human trials following the autumn holidays


Reuters
October 16, 2020
The American company said the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits


PTI
October 14, 2020
Trump, who tested positive for COVID-19 on October 1 and was admitted to a military hospital for three nights and four days, declared himself cured after he was treated with an experimental antibody drug cocktail


BusinessToday.In
October 14, 2020
Dr Reddy's has teamed up with Russian Development Investment Fund (RDIF) to conduct trials and distribute 100 million doses of Sputnik V in India


Reuters
October 14, 2020
Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as tantamount to a cure in a video he posted last week


BusinessToday.In
October 13, 2020
Scientists from the University of Toronto and the Lunenfeld-Tanenbaum Research Institute at Sinai Health used both blood samples and saliva from coronavirus patients to assess and compare antibody levels for over three months post the onset of the first symptom


Reuters
October 10, 2020
The agreement, under the Trump administration's Operation Warp Speed, is for developing a monoclonal antibody cocktail that can prevent COVID-19


BusinessToday.In
New Delhi, October 9, 2020
Eli Lilly, Gates Foundation sign deal to supply COVID-19 drugs to low, middle-income countriesEli Lilly and Co said on Thursday it had entered into an agreement with the Bill & Melinda Gates Foundation for potential supply of its experimental antibody treatments for COVID-19 to low and middle-income countries. As part of the deal, Lilly said it will make antibody therapies available to lower-income countries prior to April 2021, but did not elaborate on the number of doses. Separately, F...


PAGES 1 OF 5  12345